Ghrelin promotes hepatic lipogenesis by activation of mTOR-PPARγ signaling pathway

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 36, 2014, Pages 13163-13168

  Li, Ziru ^a   Xu, Geyang ^a   Qin, Yan ^a   Zhang, Chao ^b   Tang, Hong ^a   Yin, Yue ^a   Xiang, Xinxin ^a   Li, Yin ^a   Zhao, Jing ^a   Mulholland, Michael ^b   Zhang, Weizhen ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Gastric hormone; GHSR; Growth hormone secretagogue receptor; NAFLD

Indexed keywords

GHRELIN; GHRELIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN BINDING; TARGET OF RAPAMYCIN KINASE;

ANIMAL; C57BL MOUSE; DRUG EFFECTS; FATTY LIVER; GENE DELETION; KNOCKOUT MOUSE; LIPOGENESIS; LIVER; LIVER CELL; MALE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; FATTY LIVER; GENE DELETION; GHRELIN; HEPATOCYTES; LIPOGENESIS; LIVER; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; PPAR GAMMA; PROTEIN BINDING; RECEPTORS, GHRELIN; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84906979475     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1411571111     Document Type: Article

References (28)

1. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346(16):1221-1231.
2. Date Y, et al. (2000) Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141(11):4255-4261.
3. Ariyasu H, et al. (2001) Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 86(10):4753-4758.
4. Rodríguez A, et al. (2009) Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. Int J Obes (Lond) 33(5):541-552.
5. Sangiao-Alvarellos S, et al. (2009) Central ghrelin regulates peripheral lipid metabolism in a growth hormone-independent fashion. Endocrinology 150(10):4562-4574.
6. Davies JS, et al. (2009) Ghrelin induces abdominal obesity via GHS-R-dependent lipid retention. Mol Endocrinol 23(6):914-924.
7. Perez-Tilve D, et al. (2011) Ghrelin-induced adiposity is independent of orexigenic effects. FASEB J 25(8):2814-2822.
8. Theander-Carrillo C, et al. (2006) Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest 116(7):1983-1993.
9. Murakami N, et al. (2002) Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats. J Endocrinol 174(2):283-288.
10. Nogueiras R, et al. (2007) The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest 117(11):3475-3488.
11. Chen HY, et al. (2004) Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 145(6):2607-2612.
12. Elmquist JK, Elias CF, Saper CB (1999) From lesions to leptin: Hypothalamic control of food intake and body weight. Neuron 22(2):221-232.
13. Murphy KG, Bloom SR (2006) Gut hormones and the regulation of energy homeostasis. Nature 444(7121):854-859.
14. Sainsbury A, Zhang L (2012) Role of the hypothalamus in the neuroendocrine regulation of body weight and composition during energy deficit. Obesity Rev 13(3):234-257.
15. Dampney RA, et al. (2005) Long-term regulation of arterial blood pressure by hypothalamic nuclei: Some critical questions. Clin Exp Pharmacol Physiol 32(5-6):419-425.
16. Kim MS, et al. (2004) The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. Mol Endocrinol 18(9):2291-2301.
17. Lin L, et al. (2011) Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues. Aging Cell 10(6):996-1010.
18. Thompson NM, et al. (2004) Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 145(1):234-242.
19. Lippl F, et al. (2012) Low-dose ghrelin infusion - evidence against a hormonal role in food intake. Regul Pept 174(1-3):26-31.
20. Kohno D, Sone H, Minokoshi Y, Yada T (2008) Ghrelin raises [Ca2+]i via AMPK in hypothalamic arcuate nucleus NPY neurons. Biochem Biophys Res Commun 366(2):388-392.
21. Porteiro B, et al. (2013) Ghrelin requires p53 to stimulate lipid storage in fat and liver. Endocrinology 154(10):3671-3679.
22. Kim JE, Chen J (2004) Regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes 53(11):2748-2756.
23. Ferré P (2004) The biology of peroxisome proliferator-activated receptors: Relationship with lipid metabolism and insulin sensitivity. Diabetes 53(Suppl 1):S43-S50.
24. Cariou B, Charbonnel B, Staels B (2012) Thiazolidinediones and PPARγ agonists: Time for a reassessment. TEM 23(5):205-215.
25. Matsusue K, et al. (2003) Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest 111(5):737-747.
26. Memon RA, et al. (2000) Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: Troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 141(11):4021-4031.
27. Bedoucha M, Atzpodien E, Boelsterli UA (2001) Diabetic KKAy mice exhibit increased hepatic PPARgamma1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones. J Hepatol 35(1):17-23.
28. Xu G, et al. (2012) Ghrelin contributes to derangements of glucose metabolism induced by rapamycin in mice. Diabetologia 55(6):1813-1823.